Commercial

The most effective wrap around solution for Infection Control, delivered by a Cabinet Office listed COVID-19 support partner.

Infection control has become a clear and present risk for Commercial businesses. Whether its providing protection for your staff, your tenants, your customers, your Students, its become a critical business risk to acknowledge, to provide confidence and to demonstrate that you are taking effective action.

The Commercial sector is currently being bombarded by Companies offering to sanitise your premises. Most claim to be safe and effective, some claim to have come from a Clinical background.

When you consider the services on offer you should ask some fairly straightforward questions. Does the chemical being used contain bleach or bleaching agents? Does the space being treated have to be clear of Humans, Animals and sensitive electrical equipment? Do the operatives have to wear protective equipment when applying the treatment?

If the answer is yes to any or all of these questions you should ask yourself what is being used in your environment.

Whilst these treatments are effective, they require an understanding about the residual effects, both on surfaces or in the air and they are all time sensitive with regard to effectiveness.

For example, a bleach based cleaning product removes pathogens when applied, but 1 hour later re infection can take place. Using bleach based products also has a number of serious and hazardous side effects, bleach is aggressive, it eats away at any surface it touches and repeated application can damage electrical systems, soft furnishings, clothing and it’s easily transferred by human contact.
Other methods which use Ozone Generators or UV light systems carry their own, quite considerable health risks as a result of their aggressive structure.

All of these methods require an environment clear of any Human occupation and sensitive electrical equipment and they all, without exception can cause damage to surfaces, electrical cables, rubber hoses and connections. They also require extensive PPE or access risk control measures during and after treatment cycles.

The treatment cycles are therefore invasive, they take time, they remove access to facilities and they do leave a residual risk. They also do not tend to be linked to a regular swab testing regime to demonstrate efficacy.